Positron Emission Tomography with [<scp><sup>18</sup>F</scp>]‐<scp>DPA</scp>‐714 Unveils a Smoldering Component in Most Multiple Sclerosis Lesions which Drives Disease Progression
Mariem Hamzaoui(Inserm), Bruno Stankoff(Pitié-Salpêtrière Hospital), Martina Absinta(Johns Hopkins University), Michel Bottlaender(Centre National de la Recherche Scientifique), Théodore Soulier(Centre National de la Recherche Scientifique), Céline Louapre(Inserm), Philippe Gervais(Centre National de la Recherche Scientifique), Vito A. G. Ricigliano(Inserm), J. Garcia(Centre National de la Recherche Scientifique), Giacomo Boffa(Centre National de la Recherche Scientifique), Andrea Lazzarotto(Centre National de la Recherche Scientifique), Benedetta Bodini(Inserm), Mattéo Tonietto(Centre National de la Recherche Scientifique), Anne Bissery(Sorbonne Université)
Cited by 69
Related Papers
Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo
|JAMA Neurology|2019|520
Myelin-oligodendrocyte glycoprotein antibody-associated disease
|The Lancet Neurology|2021|518
A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis
|PLoS ONE|2013|511
Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions
|Journal of Clinical Investigation|2016|339
Brain atrophy and lesion load predict long term disability in multiple sclerosis
|Journal of Neurology Neurosurgery & Psychiatry|2013|327